Kiltz Uta, Lalazi Brikena, Baraliakos Xenofon
Rheumazentrum Ruhrgebiet, Ruhr-Universität Bochum, Claudiusstr 45, 44649, Herne, Deutschland.
Z Rheumatol. 2023 Jun;82(5):380-388. doi: 10.1007/s00393-023-01357-y. Epub 2023 May 30.
A standardized documentation of the clinical manifestation and patient-reported outcome (PRO) of patients with axial spondylarthritis (axSpA) is necessary in order to assess the disease with respect to disease activity and severity and to achieve the foundations for clinical decisions. The standardized documentation refers to domains such as disease activity, quality of life, functional capacity and ability to work but also to individual aspects, such as pain, arthritis and enthesitis. The domains as well as the individual aspects are mainly collected directly from PROs using a self-report questionnaire. An exception is the clinical examination of the inflammatory involvement of joints, entheses and the physical examination of spinal mobility. In interventional studies, status or response criteria are used to quantify changes. The lack of objective clinical criteria for documentation of inflammatory activity poses a particular challenge in axSpA, therefore, the PROs need to be interpreted critically taking objective disease parameters into consideration. Most instruments were developed in the 1990s in Bath, UK and in the last 15 years by the Assessments in Axial Spondylarthritis International Society (ASAS) for use in studies.
为了评估轴性脊柱关节炎(axSpA)患者的疾病活动度和严重程度,并为临床决策奠定基础,对其临床表现和患者报告结局(PRO)进行标准化记录是必要的。标准化记录涉及疾病活动度、生活质量、功能能力和工作能力等领域,也涉及疼痛、关节炎和附着点炎等个体方面。这些领域以及个体方面主要通过自我报告问卷直接从患者报告结局中收集。关节炎症受累的临床检查、附着点检查以及脊柱活动度的体格检查是例外情况。在干预性研究中,使用状态或反应标准来量化变化。在axSpA中,缺乏用于记录炎症活动的客观临床标准是一个特殊挑战,因此,需要结合客观疾病参数对患者报告结局进行批判性解读。大多数工具是20世纪90年代在英国巴斯开发的,以及在过去15年中由国际轴性脊柱关节炎评估协会(ASAS)开发用于研究。